Dog /

Breed profile · FDA CVM July 2026 extract

Portuguese Water Dog adverse-event record

Adverse-event filings for Portuguese Water Dog (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#122 of 510
by report volume (all breeds)
718
FDA CVM reports on file
3.6%
death-coded share of reports
#200 of 275
by death-coded share (≥50 reports)

How the 718 reports break down

By recorded gender -- every report on file for Portuguese Water Dog, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 64 48 32 16 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Portuguese Water Dog drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Portuguese Water Dog ranks #122 of 510 by total reports (718) and #200 of 275 by death-coded share (3.6%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#122
This breed, reports of 510
#200
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Portuguese Water Dog has 718 reports now versus 702 in that prior snapshot: 16 more (2.3%).

Report change
+16
Death-coded reports
+0
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Portuguese Water Dog changes

Total Reports

718

High report volume

Deaths Reported

26

of 718 reports

Death-coded share of reports

3.6%

Below-median death-coded share

Avg Age at Report

5.0 yr

22.7 kg avg weight

Breed Safety Scorecard

C- (54/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate B
3.6%

Share of reports coded as a fatality

Euthanasia rate C
1.9%

Share of reports resulting in euthanasia

Full recovery rate D
28.1%

Share of reports coded "Recovered/Normal"

5-year trend F
+45%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Portuguese Water Dog death-coded reports 3.6%
Cross-breed median

3.6% of 718 portuguese water dog reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Portuguese Water Dog's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

4% 27th percentile Higher share than 27% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Portuguese Water Dog 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 22.7 kg (50.1 lbs)

Top Reported Reactions

Vomiting 160
Lack of efficacy (endoparasite) - hookworm 55
Diarrhoea 55
Lethargy (see also Central nervous system depression in 'Neurological') 55
Digestive tract disorder NOS 41
Emesis 39
Lack of efficacy (bacteria) - Borrelia 39
Anorexia 32

Most Referenced Drugs

Ivermectin + Pyrantel As Pamoate Salt 91
Pyrantel Pamoate;Sarolaner 77
Afoxolaner 73
Milbemycin Oxime + Spinosad 70
Oclacitinib Maleate 37
Fluralaner Chew Tablets 33
Milbemycin Oxime + Praziquantel 31
Spinosad 24

Outcome Breakdown

Outcome Unknown
229 (34.3%)
Recovered/Normal
202 (30.2%)
Ongoing
195 (29.2%)
Recovered with Sequela
16 (2.4%)
Euthanized
14 (2.1%)
Died
12 (1.8%)

Gender Distribution

Male 370 (51.5%)
Female 334 (46.5%)
Unknown 10 (1.4%)
Mixed 4 (0.6%)

Reports by Year

Year Reports Trend
2010 24
2011 28
2012 45
2013 39
2014 42
2015 45
2016 59
2017 54
2018 54
2019 40
2020 39
2021 44
2022 38
2023 41
2024 50
2025 64
2026 12

Portuguese Water Dog: low death-coded share in the FDA CVM extract

Signature read: 718 reports place Portuguese Water Dog in the upper third of breed filing volume (#122 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Portuguese Water Dog sits at #122 of 510 by report volume among all breeds and #103 of 298 among dog breeds, with 718 reports and 26 (3.6%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #200 of 275. Mean age at report: 5.0 years, average weight 22.7 kg (50.1 lbs).

Top reported signs: Vomiting (160), Lack of efficacy (endoparasite) - hookworm (55), Diarrhoea (55). Most-referenced drug: Ivermectin + Pyrantel As Pamoate Salt (91 reports), followed by Pyrantel Pamoate;Sarolaner (77) and Afoxolaner (73).

Outcome coding on 668 status-recorded reports is dominated by Outcome Unknown (34.3%). Annual submissions ranged 12-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Portuguese Water Dog drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (3.6% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (22.7 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Portuguese Water Dog?
There are 718 adverse event reports involving Portuguese Water Dog in the FDA database, of which 26 were death-coded (3.6% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Portuguese Water Dog ranks #122 of 510 by report volume among all breeds PlainBreed indexes (#103 of 298 among dog breeds).
Where does Portuguese Water Dog sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Portuguese Water Dog is #122 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #103 of 298. Among breeds with at least 50 reports, its death-coded share ranks #200 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Portuguese Water Dog?
The most commonly reported adverse reactions for Portuguese Water Dog are Vomiting (160 reports), Lack of efficacy (endoparasite) - hookworm (55 reports), Diarrhoea (55 reports), Lethargy (see also Central nervous system depression in 'Neurological') (55 reports), Digestive tract disorder NOS (41 reports).
What drugs are most frequently associated with Portuguese Water Dog adverse events?
The drugs most frequently referenced in Portuguese Water Dog adverse event reports are Ivermectin + Pyrantel As Pamoate Salt (91 reports), Pyrantel Pamoate;Sarolaner (77 reports), Afoxolaner (73 reports), Milbemycin Oxime + Spinosad (70 reports), Oclacitinib Maleate (37 reports).
What is the average age of Portuguese Water Dog in adverse event reports?
The average age of Portuguese Water Dog at the time of adverse event reports is 5.0 years, with an average weight of 22.7 kg (50.1 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Portuguese Water Dog (Dog), extract as of July 2026 extract. 718 reports · 26 death-coded (3.6% of reports, not a mortality rate) · #122 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →